Douglas S Williamson

3PUBLICATIONS
8CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 29, 2021
Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate.

Douglas S Williamson, Garrick P Smith, Gitte K Mikkelsen

|Oct 13, 2017
Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1).

Douglas S Williamson, Garrick P Smith, Pamela Acheson-Dossang

|Sep 02, 2017
Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells.

Kenneth Thirstrup, Justus C Dächsel, Felix S Oppermann

Pageof 1

Frequent Collaborators

2 joint publications

Simon T Bedford

2 joint publications

Pawel Dokurno

2 joint publications

Allan E Surgenor

2 joint publications

Kenneth V Christensen